ENSOVIBEP

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 12:46:14 GMT 2025` Edited by `admin` on `Wed Apr 02 12:46:14 GMT 2025`
Protein Type	ANKYRIN REPEAT PROTEIN
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	PV6AA88RDU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MP-0420

Preferred Name

English

ENSOVIBEP

Official Name

English

ensovibep [INN]

Common Name

English

DESIGNED ANKYRIN REPEAT PROTEIN (SYNTHETIC BIVALENT HUMAN ALBUMIN-BINDING) FUSION PROTEIN WITH DESIGNED ANKYRIN REPEAT PROTEIN (SYNTHETIC TRIVALENT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR BINDING DOMAIN-BINDING)

Common Name

English

MP0420

Code

English

FUSION PROTEIN CONSISTING OF TWO IDENTICAL ENGINEERED ANKYRIN REPEATS-CONTAINING BINDING PROTEIN DOMAINS ANTI-(HUMAN ALBUMIN) (1-126 FUSED VIA PEPTIDYL LINKER 127GSPTPTPTTPTPTPTTPTPTPT148 TO 149-274), FUSED VIA PEPTIDYL LINKER 275GSPTPTPTTPTPTPTTPTPTPT29

Common Name

English

Ensovibep [WHO-DD]

Common Name

English

Code System Code Type Description

CAS

2451126-06-8

Created by admin on Wed Apr 02 12:46:14 GMT 2025 , Edited by admin on Wed Apr 02 12:46:14 GMT 2025

PRIMARY

NCI_THESAURUS

C179065

Created by admin on Wed Apr 02 12:46:14 GMT 2025 , Edited by admin on Wed Apr 02 12:46:14 GMT 2025

PRIMARY

FDA UNII

PV6AA88RDU

Created by admin on Wed Apr 02 12:46:14 GMT 2025 , Edited by admin on Wed Apr 02 12:46:14 GMT 2025

PRIMARY

INN

11896

Created by admin on Wed Apr 02 12:46:14 GMT 2025 , Edited by admin on Wed Apr 02 12:46:14 GMT 2025

PRIMARY

INN

SMS_ID

300000026378

Created by admin on Wed Apr 02 12:46:14 GMT 2025 , Edited by admin on Wed Apr 02 12:46:14 GMT 2025

PRIMARY

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->INHIBITOR

Amount:


					8R39BE7TJJ

SPIKE GLYCOPROTEIN (SARS-COV-2)

TARGET->LIGAND

Amount:

Related Record Type Details


					PV6AA88RDU

ENSOVIBEP

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID REMOVAL	[1_1]	N-TERMINUS			METHIONINE	AE28F7PNPL

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL